Focus: CryoPort Systems provides temperature-controlled supply chain solutions for advanced therapies across multiple therapeutic areas including oncology, neurology, and women's health. The company operates as a specialized logistics and quality infrastructure provider for the biotechnology sector.
Profile data last refreshed 5h ago · AI intelligence enriched 1w ago
Growing — net +6 jobs in 30d
13 jobs added vs 7 removed. Steady team buildout.
Best suited for supply-chain, operations, or quality professionals seeking early-stage equity upside in a nascent logistics-biotech subsector; higher risk than established pharma but potentially higher autonomy.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for CryoPort Systems
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from CryoPort Systems's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company